IVVD - Invivyd Inc
0.8459
-0.069 -8.157%
Share volume: 3,688,359
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$0.91
-0.07
-0.08%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | |
Cash flow financing | 39.101 M | 92.000 K | 61.000 K | |
Other financing cash flows | -273.000 K | 17.000 K | 34.000 K | |
Cash flow | -11.253 M | 0.000 | -41.012 M | |
Net income | -43.496 M | -47.247 M | -60.739 M | |
Depreciation | 122.000 K | 128.000 K | 132.000 K | |
Changes in inventories | 104.000 K | 0.000 | 0.000 | |
Changes in receivables | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -140.000 K | 0.000 | -5.000 K | |
Net Borrowings | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 140.000 K | 0.000 | 5.000 K | |
Cash Change | -11.253 M | -41.507 M | -41.012 M |